Entera Bio For Profit
We are a clinical stage, global company, focused on high unmet clinical needs where oral delivery of a protein therapy can significantly improve the standard of care. We are developing first-in-class, daily tablet protein and peptide replacement therapies, designed for patients to live healthier and injection-free, as they manage their chronic diseases. Our goal is for our small, oral protein tablets to change treatment outcomes for patients globally.
Founded Date:
2010-01-01
Headquarters:
Jerusalem, Yerushalayim, Israel
Technology:
Drug development
Employee Number:
11-50
Industry:
PharmTech
Estimated Revenue:
Less than $1M
Funding Status:
IPO